Literature DB >> 15692667

[Leishmaniasis in domestic dogs: epidemiological aspects].

Alba Valéria Machado da Silva1, Adelzon Assis de Paula, Maria Alice Airosa Cabrera, João Carlos Araújo Carreira.   

Abstract

In Barra de Guaratiba, an endemic area for American visceral leishmaniasis (AVL) in Rio de Janeiro, Brazil, control campaigns were unable to reduce canine infection rates. This difficulty prompted an in-depth study of dogs as a reservoir for Leishmania chagasi in the peri-urban environment through clinical and serological follow-up using the immunofluorescence and Western blot techniques. Recognition of 29 kDa and 32 kDa peptides by sera from dogs with proven L. chagasi infection was observed. Furthermore, only sera from symptomatic dogs recognized the 68.5 kDa antigen, so the latter should be considered a parameter for culling dogs from endemic areas. The WB technique proved to be more sensitive than IFA, since the 29 and 32 kDa peptide fractions were even recognized by sera from AVL seronegative dogs up to 8 months before IFA seroconversion. Proximity to wooded areas was an important risk factor for L. chagasi infection in dogs, possibly due to the presence of wild reservoirs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692667     DOI: 10.1590/s0102-311x2005000100036

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  IDENTIFICATION OF CANINE VISCERAL LEISHMANIASIS IN A PREVIOUSLY UNAFFECTED AREA BY CONVENTIONAL DIAGNOSTIC TECHNIQUES AND CELL-BLOCK FIXATION.

Authors:  Tuanne Rotti Abrantes; Maria de Fátima Madeira; Denise Amaro da Silva; Carolina dos Santos F S Perié; Artur Augusto V Mendes Júnior; Rodrigo Caldas Menezes; Valmir Laurentino Silva; Fabiano Borges Figueiredo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

2.  Evaluation of canine and feline leishmaniasis by the association of blood culture, immunofluorescent antibody test and polymerase chain reaction.

Authors:  Audrey Rennó Campos Braga; Hélio Langoni; Simone Baldini Lucheis
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-02-24

3.  Mixed infection of Leishmania infantum and Leishmania braziliensis in rodents from endemic urban area of the New World.

Authors:  Eduardo de Castro Ferreira; Israel Cruz; Carmen Cañavate; Lutiana Amaral de Melo; Agnes Antônia Sampaio Pereira; Filipe A M Madeira; Sofia Alves Nogueira Valério; Heitor Morais Cunha; Adriano Pereira Paglia; Célia Maria Ferreira Gontijo
Journal:  BMC Vet Res       Date:  2015-03-20       Impact factor: 2.741

4.  CANINE VISCERAL LEISHMANIASIS CASE INVESTIGATION IN THE JACARE REGION OF NITEROI, RIO DE JANEIRO, BRAZIL.

Authors:  Amanda Codeço de Oliveira; Fabiano Borges Figueiredo; Valmir Laurentino Silva; Fernanda Nunes Santos; Marcos Barbosa de Souza; Maria de Fátima Madeira; Tuanne Rotti Abrantes; André Reynaldo Santos Périssé
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

5.  Validity and reliability of enzyme immunoassays using Leishmania major or L. infantum antigens for the diagnosis of canine visceral leishmaniasis in Brazil.

Authors:  Mauro Maciel de Arruda; Fabiano Borges Figueiredo; Fernanda Alvarenga Cardoso; Roberto Mitsuyoshi Hiamamoto; Júlia Cristina Macksoud Brazuna; Maria Regina Fernandes de Oliveira; Elza Ferreira Noronha; Gustavo Adolfo Sierra Romero
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

6.  Canine visceral leishmaniasis in the Northeast Region of Brazil.

Authors:  Flávio Gonçalves Brito; Helio Langoni; Rodrigo Costa da Silva; Tereza Emmanuelle de Farias Rotondano; Marcia Almeida de Melo; Giselle Souza da Paz
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-04-12

7.  Seroepidemiological Survey of Canine Leishmania Infections from Peripheral Areas in Natal, Northeast Brazil.

Authors:  Isabelle Ribeiro Barbosa; Francisco Canindé Carlota; Valter Ferreira de Andrade-Neto
Journal:  Open Microbiol J       Date:  2015-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.